所有图片(1)
About This Item
经验公式（希尔记法）:
C19H16N2O2
CAS号:
分子量:
304.34
MDL號碼:
分類程式碼代碼:
41106305
PubChem物質ID:
NACRES:
NA.77
推荐产品
形狀
powder
顏色
white to yellow
溶解度
DMSO: 10 mg/mL
H2O: insoluble
SMILES 字串
OCc1ccc(o1)-c2nn(Cc3ccccc3)c4ccccc24
InChI
1S/C19H16N2O2/c22-13-15-10-11-18(23-15)19-16-8-4-5-9-17(16)21(20-19)12-14-6-2-1-3-7-14/h1-11,22H,12-13H2
InChI 密鑰
OQQVFCKUDYMWGV-UHFFFAOYSA-N
基因資訊
human ... PDE5A(8654)
應用
Yc-1作为缺氧诱导因子1α （HIF-1α）抑制剂，用于：
- 减少心肌细胞（CM）中缺氧诱导Jagged1的表达
- 研究其对祖细胞扩增、CD34 +和侧群（SP）细胞表型的影响，以及对有能力形成长期菌落形成单位细胞增殖率的影响
- 通过激活Rho / Rho相关蛋白激酶（ROCK）途径，研究其调节对与白蛋白诱导的纤溶酶原激活物抑制剂1（PAI-1）表达结合的1-磷酸鞘氨醇（S1P）表达的调节作用。
生化／生理作用
YC-1激活可溶性鸟苷酸环化酶，防止血小板聚集和血管收缩。具有治疗循环系统疾病的潜力。Yc-1还具有在体外抑制缺氧诱导因子1α （HIF-1α）活性的能力。可作为潜在的抗血管生成抗癌剂。
可溶性鸟苷酸环化酶的 NO（一氧化氮）非依赖性激活剂。
特點和優勢
这种化合物是环核苷酸研究的特色产品。点击此处发现更多特色环核苷酸产品。在sigma.com/discover-bsm可了解更多关于生物活性小分子的其他研究领域。
儲存類別代碼
11 - Combustible Solids
水污染物質分類（WGK）
WGK 3
閃點（°F）
Not applicable
閃點（°C）
Not applicable
個人防護裝備
Eyeshields, Gloves, type N95 (US)
其他客户在看
Luke Gammon et al.
PloS one, 8(4), e62493-e62493 (2013-05-03)
The glycolytic response of hypoxic cells is primarily mediated by the hypoxia inducible factor alpha (HIF-1α) but even in the presence of abundant oxygen tumours typically show high rates of glycolysis. Higher levels of HIF-1α in tumours are associated with
Jian Kong et al.
PloS one, 7(5), e37266-e37266 (2012-05-23)
The mechanism of rapid growth of the residual tumor after radiofrequency (RF) ablation is poorly understood. In this study, we investigated the effect of hyperthermia on HepG2 cells and generated a subline with enhanced viability and dys-regulated angiogenesis in vivo
Kota Wakiyama et al.
Scientific reports, 7(1), 12653-12653 (2017-10-06)
This study aimed to establish a therapeutic strategy targeting hypoxic cancer cells in gastric carcinoma (GC). YC-1 is a HIF-1α inhibitor, and we revealed that low-dose YC-1 (10 µM) suppressed HIF-1α expression, and induced hypoxia-dependent apoptosis in the GC cell line
Zong-Tao Chai et al.
PloS one, 8(10), e77957-e77957 (2013-11-07)
microRNAs (miRNAs) have been reported to regulate angiogenesis by down-regulating the expression of pro-angiogenic or anti-angiogenic factors. The aims of this study were to investigate whether miR-26a inhibited angiogenesis by down-regulating vascular endothelial growth factor A (VEGFA) and its clinical
YC-1: a potential anticancer drug targeting hypoxia-inducible factor 1
Yeo EJ, et al.
Journal of the National Cancer Institute, 95(7), 516-525 (2003)
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系技术服务部门